DePrince Race & Zollo Inc (DRZ)’s Encompass Health EHC Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio EHC Stock Details EHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-416,813	Closed	-$22.5M	–	197
2023 Q1	$22.5M	Sell	416,813 -184,192	-31%	-$10.7M	0.52%	87
2022 Q4	$35.9M	Sell	601,005 -255,764	-30%	-$13.9M	0.82%	35
2022 Q3	$38.8M	Sell	856,769 -717,404	-46%	-$35.9M	0.99%	24
2022 Q2	$70.2M	Sell	1,574,173 -108,676	-6%	-$5.58M	1.62%	2
2022 Q1	$95.2M	Buy	1,682,849 +748,131	+80%	+$39.1M	1.85%	2
2021 Q4	$48.5M	Buy	+934,718	New	+$48.2M	1.23%	5
2018 Q2	–	Sell	-498,072	Closed	-$22.7M	–	236
2018 Q1	$22.7M	Sell	498,072 -162,356	-25%	-$6.96M	0.53%	86
2017 Q4	$26M	Sell	660,428 -8,672	-1%	-$330K	0.58%	75
2017 Q3	$24.7M	Buy	669,100 +197,777	+42%	+$7.05M	0.55%	82
2017 Q2	$18.1M	Sell	471,323 -2,267	-0.5%	-$83K	0.37%	123
2017 Q1	$16.1M	Buy	+473,590	New	+$15.6M	0.33%	130

Other funds holding EHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s EHC Position: Q2 2023 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Encompass Health (EHC) in Q2 2023, closing a stake of 416,813 shares — an estimated $22.5M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in EHC in Q1 2017 and held it in 11 quarters. The position peaked at $95.2M in Q1 2022. 387 funds tracked by Wall St. Rank hold EHC as of Q2 2023.

DePrince Race & Zollo Inc (DRZ) reported no remaining Encompass Health position as of Q2 2023 after selling out during the quarter.
DePrince Race & Zollo Inc (DRZ) sold 416,813 Encompass Health shares in Q2 2023, an estimated $22.5M.
DePrince Race & Zollo Inc (DRZ) first reported a position in Encompass Health in Q1 2017 and held it in 11 quarters.
DePrince Race & Zollo Inc (DRZ)'s Encompass Health position peaked at $95.2M in Q1 2022.
387 funds tracked by Wall St. Rank held Encompass Health as of Q2 2023.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q2 2023, filed 14 Aug 2023.